Framatome and KHNP explore medical isotope production at South Korea
Framatome and Korea Hydro and Nuclear Power (KHNP) have entered a Memorandum of Understanding (MoU) to explore the production of non-carrier added Lutetium-177, a critical medical isotope used in cancer treatments, at the Wolsong nuclear power plant in South Korea. The companies will conduct a joint technical assessment using Framatome's proprietary isotope production technology, already o